ERS Genomics Limited (‘ERS’) completes licensing agreement with Syngene International, India’s leading Contract Research, Development and Manufacturing Organization Syngene gains access to ERS Genomics’ foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.